2.26 score from hupso.pl for:
aidsmap.com



HTML Content


Title hiv & aids information :: home

Length: 39, Words: 5
Description nam and aidsmap work to change lives by sharing information about hiv and aids. we believe independent, clear and accurate information is vital in the fight against hiv and aids

Length: 177, Words: 30
Keywords pusty
Robots
Charset UTF-8
Og Meta - Title exist
Og Meta - Description exist
Og Meta - Site name pusty
Tytuł powinien zawierać pomiędzy 10 a 70 znaków (ze spacjami), a mniej niż 12 słów w długości.
Meta opis powinien zawierać pomiędzy 50 a 160 znaków (łącznie ze spacjami), a mniej niż 24 słów w długości.
Kodowanie znaków powinny być określone , UTF-8 jest chyba najlepszy zestaw znaków, aby przejść z powodu UTF-8 jest bardziej międzynarodowy kodowaniem.
Otwarte obiekty wykresu powinny być obecne w stronie internetowej (więcej informacji na temat protokołu OpenGraph: http://ogp.me/)

SEO Content

Words/Characters 3117
Text/HTML 22.58 %
Headings H1 1
H2 1
H3 16
H4 7
H5 14
H6 3
H1
home
H2
new design of hiv factsheets
H3
new design of hiv factsheets
new prep trial for 2017
antiretroviral drugs chart
conference news: the liver meeting
new website: about hiv / pro vich
sign up
recently diagnosed
clinic portal
find an hiv service
connect with nam
aidsmap hiv & aids news
editor's picks from other sources
e-atlas algeria
a to z of topics
a to z of drugs
nam blog
H4 united states: syringe service use up, but a third of people who inject drugs still share needles
electronic monitoring of antiretroviral adherence in "real time" boosts pill taking and need for intensive adherence support
hepatitis c virus infection is rising among gay and bisexual men in san diego
nhs england announces major new prep trial for 2017
survey finds good knowledge of prep in europe and a considerable amount of unsupported informal prep use
there may be fewer people living with undiagnosed hiv in the uk than previously thought
cdc releases new data on hiv diagnosis and prevalence in the united states
H5 hiv viral load testing capacities progress, require global support, multiple partners to reach 90-90-90 goals
first who prequalified hepatitis c rapid test opens the door to expanded treatment
israeli health ministry slammed for 'dragging feet' on new hiv drug
israel: hiv infected bodies are being segregated and covered in concrete by health officials
why over 45s are at risk of sexually transmitted infections – new findings
male circumcision in uganda will only improve if local beliefs are considered
response to nhs england announcement on prep
hepatitis c drugs australia's most expensive, cost taxpayers $1 billion in four months
the philippines: no country for poor men
why male couples should think about hiv in their relationships
prep in the uk: terms and conditions will apply
questions about the prep implementation study
find news, resources and services from algeria
or select a country from the list below
H6 more
aidsmap news feeds
email updates
strong
nam publications
b
i
nam publications
em
Bolds strong 1
b 0
i 1
em 0
Zawartość strony internetowej powinno zawierać więcej niż 250 słów, z stopa tekst / kod jest wyższy niż 20%.
Pozycji używać znaczników (h1, h2, h3, ...), aby określić temat sekcji lub ustępów na stronie, ale zwykle, użyj mniej niż 6 dla każdego tagu pozycje zachować swoją stronę zwięzły.
Styl używać silnych i kursywy znaczniki podkreślić swoje słowa kluczowe swojej stronie, ale nie nadużywać (mniej niż 16 silnych tagi i 16 znaczników kursywy)

Statystyki strony

twitter:title pusty
twitter:description pusty
google+ itemprop=name pusty
Pliki zewnętrzne 20
Pliki CSS 10
Pliki javascript 10
Plik należy zmniejszyć całkowite odwołanie plików (CSS + JavaScript) do 7-8 maksymalnie.

Linki wewnętrzne i zewnętrzne

Linki 481
Linki wewnętrzne 462
Linki zewnętrzne 19
Linki bez atrybutu Title 481
Linki z atrybutem NOFOLLOW 0
Linki - Użyj atrybutu tytuł dla każdego łącza. Nofollow link jest link, który nie pozwala wyszukiwarkom boty zrealizują są odnośniki no follow. Należy zwracać uwagę na ich użytkowania

Linki wewnętrzne

home /
news /news
latest news /latest-news
united states: syringe service use up, but a third of people who inject drugs still share needles /united-states-syringe-service-use-up-but-a-third-of-people-who-inject-drugs-still-share-needles/page/3103408/
electronic monitoring of antiretroviral adherence in "real time" boosts pill taking and need for intensive adherence support /electronic-monitoring-of-antiretroviral-adherence-in-real-time-boosts-pill-taking-and-need-for-intensive-adherence-support/page/3101124/
hepatitis c virus infection is rising among gay and bisexual men in san diego /hepatitis-c-virus-infection-is-rising-among-gay-and-bisexual-men-in-san-diego/page/3101550/
features /latest-news#featureslist
new $90-$90-$90 target needed for global viral hepatitis, hiv and tb treatment /new-90-90-90-target-needed-for-global-viral-hepatitis-hiv-and-tb-treatment/page/3101194/
policy makers' inaction is leading people to take prep 'in the wild' /policy-makers-inaction-is-leading-people-to-take-prep-in-the-wild/page/3093976/
rings, films or inserts? researchers need to develop prevention products that make sense in women’s lives /rings-films-or-inserts-researchers-need-to-develop-prevention-products-that-make-sense-in-womens-lives/page/3101193/
media reports of a british hiv cure 'breakthrough' are premature /media-reports-of-a-british-hiv-cure-breakthrough-are-premature/page/3087975/
easl issues new hepatitis c treatment recommendations for all genotypes /easl-issues-new-hepatitis-c-treatment-recommendations-for-all-genotypes/page/3088069/
news by topic /news/news-by-topic/page/1404239/
hiv update /hiv-update
news feeds /news/news-feeds/page/1444172/
conference news /conferences
hiv basics /hiv-basics
hiv & aids /hiv-basics/hiv-aids/page/1412437/
transmission /hiv-basics/transmission/page/1412438/
testing /hiv-basics/testing/page/1412439/
treatment /hiv-basics/treatment/page/1412440/
just diagnosed /hiv-basics/just-diagnosed/page/1412441/
looking for support in your area? /hiv-basics/looking-for-support-in-your-area/page/1412442/
topics /topics
testing and health monitoring /testing-and-health-monitoring/cat/1379/
hiv testing /hiv-testing/cat/1471/
health monitoring /health-monitoring/cat/1655/
hiv treatment /hiv-treatment/cat/1378/
treatment guidelines /treatment-guidelines/cat/1469/
starting treatment /starting-treatment/cat/1670/
side-effects /side-effects/cat/1463/
adherence /adherence/cat/1464/
drug interactions and pharmacokinetics /drug-interactions-and-pharmacokinetics/cat/1465/
treatment for women /treatment-for-women/cat/1467/
resistance /resistance/cat/1461/
changing treatment /changing-treatment/cat/1462/
treatment interruptions /treatment-interruptions/cat/1466/
treatment-experienced people /treatment-experienced-people/cat/1671/
new and experimental hiv treatments /new-and-experimental-hiv-treatments/cat/1673/
outcomes and prognosis /outcomes-and-prognosis/cat/1733/
the search for a cure /the-search-for-a-cure/cat/80321/
bad science and bogus treatments /bad-science-and-bogus-treatments/cat/80329/
transmission and prevention /transmission-and-prevention/cat/1377/
infectiousness and treatment as prevention /infectiousness-and-treatment-as-prevention/cat/1624/
prep /prep/cat/1623/
how transmission occurs /how-transmission-occurs/cat/1613/
sexual transmission /sexual-transmission/cat/1614/
medical procedures and other blood-borne exposure /medical-procedures-and-other-blood-borne-exposure/cat/1617/
low and theoretical transmission risks /low-and-theoretical-transmission-risks/cat/1618/
condoms and lubricant /condoms-and-lubricant/cat/1621/
harm reduction /harm-reduction/cat/81851/
circumcision /circumcision/cat/1622/
pep /pep/cat/1455/
behaviour change interventions /behaviour-change-interventions/cat/1620/
microbicides /microbicides/cat/1453/
vaccines /vaccines/cat/1459/
spermwashing /spermwashing/cat/1626/
epidemiology and behaviour /epidemiology-and-behaviour/cat/1734/
hiv prevention policy /hiv-prevention-policy/cat/80322/
structural factors /structural-factors/cat/80815/
social and legal issues /social-and-legal-issues/cat/1525/
telling people you have hiv /telling-people-you-have-hiv/cat/1537/
finding support /finding-support/cat/1535/
hiv and criminal law /hiv-and-criminal-law/cat/1686/
drug policy and policing /drug-policy-and-policing/cat/82203/
immigration /immigration/cat/1527/
money, benefits and housing /money-benefits-and-housing/cat/1529/
employment /employment/cat/1684/
religion and faith /religion-and-faith/cat/1644/
confidentiality, consent and medical ethics /confidentiality-consent-and-medical-ethics/cat/1687/
travel /travel/cat/1688/
end-of-life issues /end-of-life-issues/cat/1530/
experiences of stigma /experiences-of-stigma/cat/80323/
discrimination and the law /discrimination-and-the-law/cat/80324/
human rights /human-rights/cat/80325/
combatting stigma /combatting-stigma/cat/80326/
history of hiv and aids /history-of-hiv-and-aids/cat/80327/
people and personal stories /people-and-personal-stories/cat/82754/
hepatitis and hiv /hepatitis-and-hiv/cat/1508/
hepatitis c /hepatitis-c/cat/1509/
hepatitis b /hepatitis-b/cat/1510/
hepatitis a /hepatitis-a/cat/1627/
families and children /families-and-children/cat/1482/
prevention of mother-to-child transmission /prevention-of-mother-to-child-transmission/cat/1483/
hiv treatment in children /hiv-treatment-in-children/cat/1661/
infant feeding /infant-feeding/cat/1718/
conception /conception/cat/1488/
disclosure and children /disclosure-and-children/cat/1484/
diagnosing children /diagnosing-children/cat/1485/
hiv in children /hiv-in-children/cat/1660/
child developmental issues /child-developmental-issues/cat/1487/
support for families and children /support-for-families-and-children/cat/1662/
reproductive health /reproductive-health/cat/80812/
tuberculosis and hiv /tuberculosis-and-hiv/cat/1502/
tb vaccine /tb-vaccine/cat/1666/
tb transmission /tb-transmission/cat/1667/
tb prevention /tb-prevention/cat/1668/
tb symptoms /tb-symptoms/cat/1669/
tb diagnosis /tb-diagnosis/cat/1504/
tb treatment /tb-treatment/cat/1506/
drug-resistant tb /drug-resistant-tb/cat/1503/
tb services /tb-services/cat/1505/
hiv and sex /hiv-and-sex/cat/1540/
safer sex /safer-sex/cat/1546/
relationships and feelings /relationships-and-feelings/cat/1663/
contraception /contraception/cat/1544/
sexually transmitted infections /sexually-transmitted-infections/cat/1542/
health services and systems /health-services-and-systems/cat/1513/
delivery of care /delivery-of-care/cat/1519/
task shifting /task-shifting/cat/1717/
uk health services /uk-health-services/cat/1680/
palliative care /palliative-care/cat/1715/
epidemiology /epidemiology/cat/1682/
clinical trials /clinical-trials/cat/1683/
policy /policy/cat/1716/
activism /activism/cat/1645/
pharmaceutical industry /pharmaceutical-industry/cat/1646/
finance and funding /finance-and-funding/cat/1651/
global health initiatives /global-health-initiatives/cat/1650/
access to medicines and treatment /access-to-medicines-and-treatment/cat/80320/
retention and linkage to care /retention-and-linkage-to-care/cat/80814/
achieving the 90-90-90 target /achieving-the-90-90-90-target/cat/82765/
health problems /health-problems/cat/1489/
kidney problems /kidney-problems/cat/1723/
ageing and hiv /ageing-and-hiv/cat/1985/
mental and emotional health /mental-and-emotional-health/cat/1500/
opportunistic infections /opportunistic-infections/cat/1495/
cancer /cancer/cat/1679/
cardiovascular disease /cardiovascular-disease/cat/1493/
diabetes /diabetes/cat/1494/
malaria /malaria/cat/1499/
neurological and cognitive problems /neurological-and-cognitive-problems/cat/1719/
bone problems /bone-problems/cat/1724/
lipodystrophy /lipodystrophy/cat/1616/
malnutrition /malnutrition/cat/1642/
how hiv works /how-hiv-works/cat/1440/
what is hiv? /what-is-hiv/cat/1444/
what is aids? /what-is-aids/cat/1443/
how hiv causes disease /how-hiv-causes-disease/cat/1445/
healthy living /healthy-living/cat/1380/
mental and emotional health /mental-and-emotional-health/cat/1476/
nutrition /nutrition/cat/1480/
exercise /exercise/cat/1478/
recreational drug use /recreational-drug-use/cat/1477/
alcohol /alcohol/cat/1674/
smoking /smoking/cat/1481/
complementary therapies /complementary-therapies/cat/1675/
immunisations /immunisations/cat/1676/
sleep /sleep/cat/1677/
living well with a low cd4 count /living-well-with-a-low-cd4-count/cat/1678/
view full list of topics /topics
resources /resources
featured resources /resources
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
your next steps /your-next-steps/page/1412486/
view a full list of nam's resources /resources
the basics /thebasics
booklets /booklets
apps and online tools /apps
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
translations /translations
arabic /arabic
armenian /translations/armenian/page/3097762/
dutch (nederlands) /dutch
finnish (suomen kieli) /finnish
french (français) /fr
georgian /translations/georgian/page/3097990/
german (deutsch) /german
hebrew /hebrew
italian (italiano) /italian
kazakh (қазақ) /translations/kazakh/page/3098009/
norwegian (norsk) /norwegian
polish (polski) /polish
portuguese (português) /pt
romanian (română) /ro
russian (русский) /ru
somali /translations/somali/page/1563375/
spanish (español) /es
swedish (svenska) /swedish
thai /thai
turkish (türk) /turkish
ukrainian (yкраїнський) /translations/ukrainian-y/page/3097656/
translating our resources /translations/translating-our-resources/page/1443865/
e-atlas /e-atlas
search for hiv services across the world /e-atlas
get country-specific news and resources /e-atlas/country/
search for hiv services in the uk /e-atlas/uk/
about us /aboutus
nam blog /nam-blog
start here – our factsheets on hiv prevention and treatment /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
world aids day /world-aids-day/page/3101205/
launch of about hiv / pro vich website /launch-of-about-hiv-pro-vich-website/page/3093196/
who we are /aboutus/who-we-are/page/1276062/
what we do /aboutus/what-we-do/page/1277746/
maintaining high standards /aboutus/maintaining-high-standards/page/1439294/
how you can support us /aboutus/how-you-can-support-us/page/1439295/
how your support makes a difference /aboutus/how-your-support-makes-a-difference/page/1439296/
confidentiality /aboutus/confidentiality/page/1439297/
using nam’s resources /aboutus/using-nams-resources/page/1439298/
contact us /contact
donate /donate
more about us > /aboutus
- /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
new design of hiv factsheets /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
visit our factsheets page /factsheets
find out more in our blog /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
- /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
new design of hiv factsheets /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
visit our factsheets page /factsheets
find out more in our blog /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
- /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
new prep trial for 2017 /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
read more about the trial in our news story /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
read how to get prep in the uk /how-to-get-prep-in-the-uk/page/3089865/
read pre-exposure prophylaxis (prep) /pre-exposure-prophylaxis-prep/page/2989437/
- /resources/antiretroviral-drugs-chart/page/1412453/
antiretroviral drugs chart /resources/antiretroviral-drugs-chart/page/1412453/
view the drugs chart online /resources/antiretroviral-drugs-chart/page/1412453/
- /abbvie-pangenotypic-combination-cures-98-or-above-across-genotypes/page/3099713/
conference news: the liver meeting /abbvie-pangenotypic-combination-cures-98-or-above-across-genotypes/page/3099713/
abbvie pangenotypic combination cures 98% or above across genotypes /abbvie-pangenotypic-combination-cures-98-or-above-across-genotypes/page/3099713/
people with hiv and hcv co-infection see good hcv cure rates in real-world practice in madrid /people-with-hivhcv-co-infection-see-good-cure-rates-in-real-world-practice-in-madrid/page/3100705/
visit our liver meeting webpages /aasld-2016
- /launch-of-about-hiv-pro-vich-website/page/3093196/
new website: about hiv / pro vich /launch-of-about-hiv-pro-vich-website/page/3093196/
find out more on the nam blog /launch-of-about-hiv-pro-vich-website/page/3093196/
sign up /bulletins
recently diagnosed /hiv-basics/just-diagnosed/page/1412441/
find an hiv service /e-atlas
connect with nam /aboutus/contact/social-media/page/1563489/
united states: syringe service use up, but a third of people who inject drugs still share needles /united-states-syringe-service-use-up-but-a-third-of-people-who-inject-drugs-still-share-needles/page/3103408/
harm reduction /news/news-by-topic/harm-reduction/cat/81851/page/1404239/
... /united-states-syringe-service-use-up-but-a-third-of-people-who-inject-drugs-still-share-needles/page/3103408/
electronic monitoring of antiretroviral adherence in "real time" boosts pill taking and need for intensive adherence support /electronic-monitoring-of-antiretroviral-adherence-in-real-time-boosts-pill-taking-and-need-for-intensive-adherence-support/page/3101124/
adherence /news/news-by-topic/adherence/cat/1464/page/1404239/
... /electronic-monitoring-of-antiretroviral-adherence-in-real-time-boosts-pill-taking-and-need-for-intensive-adherence-support/page/3101124/
hepatitis c virus infection is rising among gay and bisexual men in san diego /hepatitis-c-virus-infection-is-rising-among-gay-and-bisexual-men-in-san-diego/page/3101550/
hepatitis c transmission and prevention /news/news-by-topic/hepatitis-c-transmission-and-prevention/cat/1628/page/1404239/
... /hepatitis-c-virus-infection-is-rising-among-gay-and-bisexual-men-in-san-diego/page/3101550/
nhs england announces major new prep trial for 2017 /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
prep /news/news-by-topic/prep/cat/1623/page/1404239/
... /nhs-england-announces-major-new-prep-trial-for-2017/page/3103214/
survey finds good knowledge of prep in europe and a considerable amount of unsupported informal prep use /survey-finds-good-knowledge-of-prep-in-europe-and-a-considerable-amount-of-unsupported-informal-prep-use/page/3102845/
prep /news/news-by-topic/prep/cat/1623/page/1404239/
... /survey-finds-good-knowledge-of-prep-in-europe-and-a-considerable-amount-of-unsupported-informal-prep-use/page/3102845/
there may be fewer people living with undiagnosed hiv in the uk than previously thought /there-may-be-fewer-people-living-with-undiagnosed-hiv-in-the-uk-than-previously-thought/page/3102784/
epidemiology and behaviour /news/news-by-topic/epidemiology-and-behaviour/cat/1734/page/1404239/
... /there-may-be-fewer-people-living-with-undiagnosed-hiv-in-the-uk-than-previously-thought/page/3102784/
cdc releases new data on hiv diagnosis and prevalence in the united states /cdc-releases-new-data-on-hiv-diagnosis-and-prevalence-in-the-united-states/page/3102335/
epidemiology /news/news-by-topic/epidemiology/cat/1682/page/1404239/
... /cdc-releases-new-data-on-hiv-diagnosis-and-prevalence-in-the-united-states/page/3102335/
more news from aidsmap /latest-news
hiv viral load testing capacities progress, require global support, multiple partners to reach 90-90-90 goals /aggregator.ashx?url=http%3a%2f%2ffeedproxy.google.com%2f%7er%2fsciencespeakshivtbnews%2f%7e3%2fiqs-owkp0vo%2f
first who prequalified hepatitis c rapid test opens the door to expanded treatment /aggregator.ashx?url=http%3a%2f%2fwww.who.int%2fmedicines%2fnews%2fprequal_hvc%2fen%2f
israeli health ministry slammed for 'dragging feet' on new hiv drug /aggregator.ashx?url=http%3a%2f%2fwww.israelhayom.com%2fsite%2fnewsletter_article.php%3fid%3d38451
israel: hiv infected bodies are being segregated and covered in concrete by health officials /aggregator.ashx?url=http%3a%2f%2fwww.pinknews.co.uk%2f2016%2f12%2f02%2fexclusive-hiv-infected-bodies-are-being-segregated-and-covered-in-concrete-by-health-officials%2f
why over 45s are at risk of sexually transmitted infections – new findings /aggregator.ashx?url=https%3a%2f%2ftheconversation.com%2fwhy-over-45s-are-at-risk-of-sexually-transmitted-infections-new-findings-69539
male circumcision in uganda will only improve if local beliefs are considered /aggregator.ashx?url=https%3a%2f%2ftheconversation.com%2fmale-circumcision-in-uganda-will-only-improve-if-local-beliefs-are-considered-69270
response to nhs england announcement on prep /aggregator.ashx?url=http%3a%2f%2fwww.proud.mrc.ac.uk%2flatest_news
hepatitis c drugs australia's most expensive, cost taxpayers $1 billion in four months /aggregator.ashx?url=http%3a%2f%2fwww.abc.net.au%2fnews%2f2016-12-05%2fhep-c-drugs-australia's-most-expensive%2f8094188
the philippines: no country for poor men /aggregator.ashx?url=http%3a%2f%2fwww.bbc.co.uk%2fnews%2fworld-asia-38144237
why male couples should think about hiv in their relationships /aggregator.ashx?url=https%3a%2f%2ftheconversation.com%2fwhy-male-couples-should-think-about-hiv-in-their-relationships-68895%3futm_source%3dpl%2bfull%2bmailing%2blist%26utm_campaign%3dee74178f1c-email_campaign_2016_12_04%26utm_medium%3demail%26utm_term%3d0_e4f77dc29a-ee74178f1c-370434333
prep in the uk: terms and conditions will apply /aggregator.ashx?url=http%3a%2f%2fwww.incidence0.org%2f2016%2f12%2f04%2fprep-in-the-uk-terms-and-conditions-will-apply%2f
questions about the prep implementation study /aggregator.ashx?url=https%3a%2f%2fgregowenblog.wordpress.com%2f2016%2f12%2f04%2fnhs-to-fund-prep-for-10000-people%2f
more editor's picks /latest-news
algeria /algeria/cat/1259/
- /algeria/cat/1259/
4 services /hiv-aids-services/algeria/cat/1259/page/1871278/
1 news articles /news-and-statistics/algeria/cat/1259/page/1332400/
58 editors' picks /news-and-statistics/algeria/cat/1259/page/1332400/
15 resources /resources-and-social-media/algeria/cat/1259/page/2433517/
access to medicines and treatment /access-to-medicines-and-treatment/cat/80320/
achieving the 90-90-90 target /achieving-the-90-90-90-target/cat/82765/
activism /activism/cat/1645/
adherence /adherence/cat/1464/
africans in the uk /africans-in-the-uk/cat/1732/
ageing and hiv /ageing-and-hiv/cat/1985/
alcohol /alcohol/cat/1674/
bad science and bogus treatments /bad-science-and-bogus-treatments/cat/80329/
behaviour change interventions /behaviour-change-interventions/cat/1620/
bone problems /bone-problems/cat/1724/
cancer /cancer/cat/1679/
cardiovascular disease /cardiovascular-disease/cat/1493/
cd4 count /cd4-count/cat/1656/
changing treatment /changing-treatment/cat/1462/
child developmental issues /child-developmental-issues/cat/1487/
circumcision /circumcision/cat/1622/
clinical trials /clinical-trials/cat/1683/
combatting stigma /combatting-stigma/cat/80326/
complementary therapies /complementary-therapies/cat/1675/
conception /conception/cat/1488/
condoms and lubricant /condoms-and-lubricant/cat/1621/
confidentiality, consent and medical ethics /confidentiality-consent-and-medical-ethics/cat/1687/
contraception /contraception/cat/1544/
delivery of care /delivery-of-care/cat/1519/
diabetes /diabetes/cat/1494/
diagnosing children /diagnosing-children/cat/1485/
disclosure and children /disclosure-and-children/cat/1484/
discrimination and the law /discrimination-and-the-law/cat/80324/
drug interactions and pharmacokinetics /drug-interactions-and-pharmacokinetics/cat/1465/
drug policy and policing /drug-policy-and-policing/cat/82203/
drug-resistant tb /drug-resistant-tb/cat/1503/
employment /employment/cat/1684/
end-of-life issues /end-of-life-issues/cat/1530/
epidemiology /epidemiology/cat/1682/
epidemiology and behaviour /epidemiology-and-behaviour/cat/1734/
exercise /exercise/cat/1478/
experiences of stigma /experiences-of-stigma/cat/80323/
families and children /families-and-children/cat/1482/
finance and funding /finance-and-funding/cat/1651/
finding support /finding-support/cat/1535/
global health initiatives /global-health-initiatives/cat/1650/
harm reduction /harm-reduction/cat/81851/
health monitoring /health-monitoring/cat/1655/
health monitoring in resource-limited settings /health-monitoring-in-resource-limited-settings/cat/1659/
health problems /health-problems/cat/1489/
health services and systems /health-services-and-systems/cat/1513/
healthy living /healthy-living/cat/1380/
hepatitis a /hepatitis-a/cat/1627/
hepatitis and hiv /hepatitis-and-hiv/cat/1508/
hepatitis b /hepatitis-b/cat/1510/
hepatitis c /hepatitis-c/cat/1509/
hepatitis c symptoms and diagnosis /hepatitis-c-symptoms-and-diagnosis/cat/1631/
hepatitis c transmission and prevention /hepatitis-c-transmission-and-prevention/cat/1628/
hepatitis c treatment /hepatitis-c-treatment/cat/1632/
hepatitis c treatment side-effects /hepatitis-c-treatment-side-effects/cat/80884/
history of hiv and aids /history-of-hiv-and-aids/cat/80327/
hiv and criminal law /hiv-and-criminal-law/cat/1686/
hiv and sex /hiv-and-sex/cat/1540/
hiv in children /hiv-in-children/cat/1660/
hiv prevention policy /hiv-prevention-policy/cat/80322/
hiv testing /hiv-testing/cat/1471/
hiv treatment /hiv-treatment/cat/1378/
hiv treatment in children /hiv-treatment-in-children/cat/1661/
how hiv causes disease /how-hiv-causes-disease/cat/1445/
how hiv works /how-hiv-works/cat/1440/
how transmission occurs /how-transmission-occurs/cat/1613/
human rights /human-rights/cat/80325/
immigration /immigration/cat/1527/
immunisations /immunisations/cat/1676/
infant feeding /infant-feeding/cat/1718/
infectiousness and treatment as prevention /infectiousness-and-treatment-as-prevention/cat/1624/
kidney problems /kidney-problems/cat/1723/
lipodystrophy /lipodystrophy/cat/1616/
living well with a low cd4 count /living-well-with-a-low-cd4-count/cat/1678/
low and theoretical transmission risks /low-and-theoretical-transmission-risks/cat/1618/
malaria /malaria/cat/1499/
malnutrition /malnutrition/cat/1642/
medical procedures and other blood-borne exposure /medical-procedures-and-other-blood-borne-exposure/cat/1617/
men who have sex with men (msm) /men-who-have-sex-with-men-msm/cat/1727/
mental and emotional health /mental-and-emotional-health/cat/1476/
mental and emotional health /mental-and-emotional-health/cat/1500/
microbicides /microbicides/cat/1453/
migrants /migrants/cat/1731/
money, benefits and housing /money-benefits-and-housing/cat/1529/
neurological and cognitive problems /neurological-and-cognitive-problems/cat/1719/
new and experimental hepatitis c treatment /new-and-experimental-hepatitis-c-treatment/cat/1635/
new and experimental hiv treatments /new-and-experimental-hiv-treatments/cat/1673/
nutrition /nutrition/cat/1480/
opportunistic infections /opportunistic-infections/cat/1495/
other tests /other-tests/cat/1658/
outcomes and prognosis /outcomes-and-prognosis/cat/1733/
palliative care /palliative-care/cat/1715/
people and personal stories /people-and-personal-stories/cat/82754/
people who inject drugs /people-who-inject-drugs/cat/1728/
pep /pep/cat/1455/
pharmaceutical industry /pharmaceutical-industry/cat/1646/
policy /policy/cat/1716/
populations /populations/cat/1726/
prep /prep/cat/1623/
prevention of mother-to-child transmission /prevention-of-mother-to-child-transmission/cat/1483/
prisoners /prisoners/cat/1730/
promoting hiv testing /promoting-hiv-testing/cat/1638/
recreational drug use /recreational-drug-use/cat/1477/
relationships and feelings /relationships-and-feelings/cat/1663/
religion and faith /religion-and-faith/cat/1644/
reproductive health /reproductive-health/cat/80812/
resistance /resistance/cat/1461/
retention and linkage to care /retention-and-linkage-to-care/cat/80814/
safer sex /safer-sex/cat/1546/
sex workers /sex-workers/cat/1729/
sexual transmission /sexual-transmission/cat/1614/
sexually transmitted infections /sexually-transmitted-infections/cat/1542/
side-effects /side-effects/cat/1463/
sleep /sleep/cat/1677/
smoking /smoking/cat/1481/
social and legal issues /social-and-legal-issues/cat/1525/
spermwashing /spermwashing/cat/1626/
starting treatment /starting-treatment/cat/1670/
structural factors /structural-factors/cat/80815/
support for families and children /support-for-families-and-children/cat/1662/
taking an hiv test /taking-an-hiv-test/cat/1637/
task shifting /task-shifting/cat/1717/
tb diagnosis /tb-diagnosis/cat/1504/
tb prevention /tb-prevention/cat/1668/
tb services /tb-services/cat/1505/
tb symptoms /tb-symptoms/cat/1669/
tb transmission /tb-transmission/cat/1667/
tb treatment /tb-treatment/cat/1506/
tb vaccine /tb-vaccine/cat/1666/
telling people you have hiv /telling-people-you-have-hiv/cat/1537/
testing and health monitoring /testing-and-health-monitoring/cat/1379/
testing policies and guidelines /testing-policies-and-guidelines/cat/1653/
the search for a cure /the-search-for-a-cure/cat/80321/
transgender people /transgender-people/cat/1528/
transmission and prevention /transmission-and-prevention/cat/1377/
travel /travel/cat/1688/
treatment for women /treatment-for-women/cat/1467/
treatment guidelines /treatment-guidelines/cat/1469/
treatment interruptions /treatment-interruptions/cat/1466/
treatment-experienced people /treatment-experienced-people/cat/1671/
tuberculosis and hiv /tuberculosis-and-hiv/cat/1502/
types of hiv tests /types-of-hiv-tests/cat/1649/
uk health services /uk-health-services/cat/1680/
vaccines /vaccines/cat/1459/
viral load /viral-load/cat/1657/
what is aids? /what-is-aids/cat/1443/
what is hiv? /what-is-hiv/cat/1444/
women /women/cat/1735/
young people /young-people/cat/1640/
abacavir (ziagen) /resources/treatmentsdirectory/drugs/abacavir-iziageni/page/1730880/
atazanavir (reyataz) /resources/treatmentsdirectory/drugs/atazanavir-ireyatazi/page/1730901/
atripla /resources/treatmentsdirectory/drugs/iatriplai/page/1730903/
darunavir (prezista) /resources/treatmentsdirectory/drugs/darunavir-iprezistai/page/1730953/
descovy /resources/treatmentsdirectory/drugs/idescovyi/page/3088857/
dolutegravir (tivicay) /resources/treatmentsdirectory/drugs/dolutegravir-itivicayi/page/2857993/
efavirenz (sustiva) /resources/treatmentsdirectory/drugs/efavirenz-isustivai/page/1730999/
elvitegravir (vitekta) /resources/treatmentsdirectory/drugs/elvitegravir-ivitektai/page/2858003/
emtricitabine (ftc, emtriva) /resources/treatmentsdirectory/drugs/emtricitabine-ftc-iemtrivai/page/1731063/
etravirine (intelence) /resources/treatmentsdirectory/drugs/etravirine-iintelencei/page/1731031/
eviplera /resources/treatmentsdirectory/drugs/ieviplerai/page/2188046/
evotaz /resources/treatmentsdirectory/drugs/ievotazi/page/3088910/
fosamprenavir (telzir, lexiva) /resources/treatmentsdirectory/drugs/fosamprenavir-itelziri-ilexivai/page/1731036/
genvoya /resources/treatmentsdirectory/drugs/igenvoyai/page/3088881/
kivexa (abacavir/3tc) /resources/treatmentsdirectory/drugs/ikivexai-abacavir3tc/page/1731081/
lamivudine (3tc, epivir) /resources/treatmentsdirectory/drugs/lamivudine-3tc-iepiviri/page/1730859/
lopinavir/ritonavir (kaletra) /resources/treatmentsdirectory/drugs/lopinavirritonavir-ikaletrai/page/1731082/
maraviroc (celsentri) /resources/treatmentsdirectory/drugs/maraviroc-icelsentrii/page/1731120/
nevirapine (viramune) /resources/treatmentsdirectory/drugs/nevirapine-iviramunei/page/1731152/
odefsey /resources/treatmentsdirectory/drugs/iodefseyi/page/3088883/
raltegravir (isentress) /resources/treatmentsdirectory/drugs/raltegravir-iisentressi/page/1731168/
rezolsta /resources/treatmentsdirectory/drugs/irezolstai/page/3088912/
rilpivirine (edurant) /resources/treatmentsdirectory/drugs/rilpivirine-ieduranti/page/1731269/
ritonavir (norvir) /resources/treatmentsdirectory/drugs/ritonavir-inorviri/page/1731169/
stribild /resources/treatmentsdirectory/drugs/istribildi/page/2857997/
tenofovir (viread) /resources/treatmentsdirectory/drugs/tenofovir-ivireadi/page/1731221/
triumeq /resources/treatmentsdirectory/drugs/itriumeqi/page/3088919/
truvada (tenofovir/ftc) /resources/treatmentsdirectory/drugs/itruvadai-tenofovirftc/page/1731265/
zidovudine (azt, retrovir) /resources/treatmentsdirectory/drugs/zidovudine-azt-iretroviri/page/1730919/
start here – our factsheets on hiv prevention and treatment /start-here-our-factsheets-on-hiv-prevention-and-treatment/page/3103061/
world aids day /world-aids-day/page/3101205/
launch of about hiv / pro vich website /launch-of-about-hiv-pro-vich-website/page/3093196/
european delays on hiv prevention drug endanger gay men and others at risk of hiv /european-delays-on-hiv-prevention-drug-endanger-gay-men-and-others-at-risk-of-hiv/page/3093325/
more /nam-blog
nam’s information /accessibility-terms-of-use/page/1404310/
subscribe to our news feeds /news/news-feeds/page/1444172/
get the latest hiv news delivered to your inbox /bulletins
sitemap /sitemap/page/1404305/
accessibility & terms of use /accessibility-terms-of-use/page/1404310/
privacy & cookies /privacy-amp-cookies/page/1404311/
feedback /feedback/page/1404313/
contact us /contact-us/page/1446756/

Linki zewnętrzne

nam http://www.aidsmap.com
aidsmap http://www.aidsmap.com
visit the about hiv / pro vich website http://www.about-hiv.info/
clinic portal http://clinic.nam.org.uk/page/2945735
the information standard certified member http://www.england.nhs.uk/tis/
sign the community consensus statement on access to hiv treatment and its use for prevention http://www.hivt4p.org/
community consensus statement on access to hiv treatment and its use for prevention http://www.hivt4p.org/
community consensus statement http://www.hivt4p.org
read it http://www.hivt4p.org/#content
sign it http://www.hivt4p.org/#profile-form
share it http://www.hivt4p.org/#share-links
http://www.avac.org/
http://www.eatg.org
http://msmgf.org/
http://www.gnpplus.net/
http://i-base.info/
http://www.aidsalliance.org/
http://itpcglobal.org/
http://www.aidsmap.com/

Zdjęcia

Zdjęcia 15
Zdjęcia bez atrybutu ALT 10
Zdjęcia bez atrybutu TITLE 15
Korzystanie Obraz ALT i TITLE atrybutu dla każdego obrazu.

Zdjęcia bez atrybutu TITLE

/site/file/1213444/file.png
/v635405229440000000/file/1187291/resize/w106~c0,0,106,75/drug_chart_june_2014_web.png
/v635735895820000000/file/1187277/resize/w106~c0,0,106,75/your_next_steps_web.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w106~c0,0,106,75/factsheets_1000px.png
http://images.aidsmap.com/v634550526142400000/file/1051735/resize/w106~c0,0,106,75/donate_to_nam_ribbon.png
http://images.aidsmap.com/v636124772830030000/file/1213309/resize/w106~c0,0,106,75/about_hiv_general_1000_707.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w297~c0,0,297,210/factsheets_1000px.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w114~c0,0,114,80/factsheets_1000px.png
http://images.aidsmap.com/v636116944943700000/file/1213203/resize/w114~c0,0,114,80/prep.png
http://images.aidsmap.com/v636144661289100000/file/1213410/resize/w114~c0,0,114,80/2016_drugs_chart_1000px.png
http://images.aidsmap.com/v636150800950000000/file/1213442/resize/w114~c0,0,114,80/stefanzeuzem_1000px.jpg
http://images.aidsmap.com/v636124772830030000/file/1213309/resize/w114~c0,0,114,80/about_hiv_general_1000_707.png
http://maps.google.com/maps/api/staticmap?size=215x148&maptype=roadmap&sensor=false&center=algeria&markers=icon:http://www.aidsmap.com/file/1051347/file.png|algeria
/site/file/1213445/file.png
/site/file/1213446/file.png

Zdjęcia bez atrybutu ALT

/site/file/1213444/file.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w297~c0,0,297,210/factsheets_1000px.png
http://images.aidsmap.com/v636161025345700000/file/1213455/resize/w114~c0,0,114,80/factsheets_1000px.png
http://images.aidsmap.com/v636116944943700000/file/1213203/resize/w114~c0,0,114,80/prep.png
http://images.aidsmap.com/v636144661289100000/file/1213410/resize/w114~c0,0,114,80/2016_drugs_chart_1000px.png
http://images.aidsmap.com/v636150800950000000/file/1213442/resize/w114~c0,0,114,80/stefanzeuzem_1000px.jpg
http://images.aidsmap.com/v636124772830030000/file/1213309/resize/w114~c0,0,114,80/about_hiv_general_1000_707.png
http://maps.google.com/maps/api/staticmap?size=215x148&maptype=roadmap&sensor=false&center=algeria&markers=icon:http://www.aidsmap.com/file/1051347/file.png|algeria
/site/file/1213445/file.png
/site/file/1213446/file.png

Ranking:


Alexa Traffic
Daily Global Rank Trend
Daily Reach (Percent)









Majestic SEO











Text on page:

low graphics text only --> nam aidsmap hiv & aids - sharing knowledge, changing lives home news latest newsunited states: syringe service use up, but a third of people who inject drugs still share needles 11 hours agoelectronic monitoring of antiretroviral adherence in "real time" boosts pill taking and need for intensive adherence support 05 december 2016hepatitis c virus infection is rising among gay and bisexual men in san diego 05 december 2016featuresnew $90-$90-$90 target needed for global viral hepatitis, hiv and tb treatmentpolicy makers' inaction is leading people to take prep 'in the wild'rings, films or inserts? researchers need to develop prevention products that make sense in women’s livesmedia reports of a british hiv cure 'breakthrough' are prematureeasl issues new hepatitis c treatment recommendations for all genotypes news by topic all our news, features and news selected from other sources. hiv update a fortnightly summary of hiv research news. news feeds conference news catch up on recent news reporting from hiv glasgow, the hiv research for prevention (r4p) conference and idweek. hiv basics hiv & aids what is hiv? and what is aids? find answers to some common questions in this section. transmission how is hiv transmitted - and how is it not transmitted? find out the answers in this section. testing worried you might have hiv? have an hiv test - it's the only way to know for sure. treatment hiv treatment is not a cure, but it is keeping millions of people well. start learning about it in this section. just diagnosed in this section we have answered some of the questions you might have if you have just found out you have hiv. looking for support in your area? find healthcare services and support. topics testing and health monitoring hiv testing | health monitoring hiv treatment treatment guidelines | starting treatment | side-effects | adherence | drug interactions and pharmacokinetics | treatment for women | resistance | changing treatment | treatment interruptions | treatment-experienced people | new and experimental hiv treatments | outcomes and prognosis | the search for a cure | bad science and bogus treatments transmission and prevention infectiousness and treatment as prevention | prep | how transmission occurs | sexual transmission | medical procedures and other blood-borne exposure | low and theoretical transmission risks | condoms and lubricant | harm reduction | circumcision | pep | behaviour change interventions | microbicides | vaccines | spermwashing | epidemiology and behaviour | hiv prevention policy | structural factors social and legal issues telling people you have hiv | finding support | hiv and criminal law | drug policy and policing | immigration | money, benefits and housing | employment | religion and faith | confidentiality, consent and medical ethics | travel | end-of-life issues | experiences of stigma | discrimination and the law | human rights | combatting stigma | history of hiv and aids | people and personal stories hepatitis and hiv hepatitis c | hepatitis b | hepatitis a families and children prevention of mother-to-child transmission | hiv treatment in children | infant feeding | conception | disclosure and children | diagnosing children | hiv in children | child developmental issues | support for families and children | reproductive health tuberculosis and hiv tb vaccine | tb transmission | tb prevention | tb symptoms | tb diagnosis | tb treatment | drug-resistant tb | tb services hiv and sex safer sex | relationships and feelings | contraception | sexually transmitted infections health services and systems delivery of care | task shifting | uk health services | palliative care | epidemiology | clinical trials | policy | activism | pharmaceutical industry | finance and funding | global health initiatives | access to medicines and treatment | retention and linkage to care | achieving the 90-90-90 target health problems kidney problems | ageing and hiv | mental and emotional health | opportunistic infections | cancer | cardiovascular disease | diabetes | malaria | neurological and cognitive problems | bone problems | lipodystrophy | malnutrition how hiv works what is hiv? | what is aids? | how hiv causes disease healthy living mental and emotional health | nutrition | exercise | recreational drug use | alcohol | smoking | complementary therapies | immunisations | sleep | living well with a low cd4 count view full list of topics resources featured resourcesantiretroviral drugs charta one-page reference guide to the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions.your next stepsa booklet with information for people who’ve just found out they have hiv. view a full list of nam's resources the basics an introduction to key issues about hiv treatment and living with hiv, presented as a series of illustrated leaflets. booklets our award-winning series of booklets, with each title providing a comprehensive overview of one aspect of living with hiv. apps and online tools a range of interactive tools to support people living with hiv to get involved in decisions about their treatment and care. antiretroviral drugs chart a one-page reference guide to the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions. translations arabic armenian dutch (nederlands) finnish (suomen kieli) french (français) georgian german (deutsch) hebrew italian (italiano) kazakh (қазақ) norwegian (norsk) polish (polski) portuguese (português) romanian (română) russian (русский) somali spanish (español) swedish (svenska) thai turkish (türk) ukrainian (yкраїнський) translating our resources e-atlas search for hiv services across the worldfind contact details for over 900 key organisations in more than 189 countriesget country-specific news and resourcesan instant guide to hiv & aids in countries and regions around the worldsearch for hiv services in the ukthe most comprehensive listing of hiv-related services in the uk about us nam blogstart here – our factsheets on hiv prevention and treatment 10 hours agonam has just relaunched its series of hiv factsheets, covering some...world aids day 25 november 2016in the 1980s and 90s, even into the treatment era...launch of about hiv / pro vich website 23 october 2016on 23 october, at the hiv drug therapy conference in glasgow,... who we are what we do maintaining high standards how you can support us how your support makes a difference confidentiality using nam’s resources contact us donate home nam works to change lives by sharing information about hiv and aids. we believe independent, clear and accurate information is vital in the fight against hiv and aids. more about us > new design of hiv factsheets nam has just relaunched its series of hiv factsheets, covering some of the most important topics in hiv prevention, treatment and care.each factsheet gives a brief overview of the key aspects of a topic, providing easy-to-understand information for individuals who want to take care of their health.visit our factsheets pagefind out more in our blog new design of hiv factsheets nam has just relaunched its series of hiv factsheets, covering some of the most important topics in hiv prevention, treatment and care.each factsheet gives a brief overview of the key aspects of a topic, providing easy-to-understand information for individuals who want to take care of their health.visit our factsheets pagefind out more in our blog new prep trial for 2017 nhs england has announced that a major new three-year pre-exposure prophylaxis (prep) trial will start in 2017. it is planned to enrol at least 10,000 participants over the three years and nhs england will provide up to £10 million for the trial.read more about the trial in our news story read how to get prep in the ukread pre-exposure prophylaxis (prep) antiretroviral drugs chart a new edition of our antiretroviral drugs chart is now available online, and in print through our patient information scheme. this one-page reference guide lists all the anti-hiv drugs licensed for use in the european union, with information on formulation, dosing, key side-effects and food restrictions.view the drugs chart online conference news: the liver meeting the liver meeting 2016 took place in boston, usa, from 11-15 november. catch up on the latest hepatitis news on our conference pages.abbvie pangenotypic combination cures 98% or above across genotypespeople with hiv and hcv co-infection see good hcv cure rates in real-world practice in madridvisit our liver meeting webpages new website: about hiv / pro vich a new website (about hiv / pro vich) for people living with hiv in eastern europe and central asia was launched at the hiv glasgow conference. the website features a series of factsheets about key hiv topics, currently available in armenian, english, georgian, kazakh, russian and ukrainian. find out more on the nam blogvisit the about hiv / pro vich website sign up recently diagnosed clinic portal find an hiv service connect with nam aidsmap hiv & aids news united states: syringe service use up, but a third of people who inject drugs still share needles new harm reduction liz highleyman | 11 hours ago use of syringe exchange and distribution services has increased substantially over the past decade in the united states, and hiv diagnoses among people who inject drugs have fallen by nearly half, but ... electronic monitoring of antiretroviral adherence in "real time" boosts pill taking and need for intensive adherence support adherence michael carter | 05 december 2016 electronic monitoring of antiretroviral adherence in “real time” significantly increases the proportion of treatment doses taken on time and reduces the frequency of treatment interruptions, according to a ugandan study published in aids. ... hepatitis c virus infection is rising among gay and bisexual men in san diego hepatitis c transmission and prevention liz highleyman | 05 december 2016 the prevalence of hepatitis c virus (hcv) infection among hiv-positive men who have sex with men in san diego has increased over the past 15 years, especially among men who do not ... nhs england announces major new prep trial for 2017 prep gus cairns | 04 december 2016 nhs england, in collaboration with public health england, has announced in a press release today that a major new implementation trial of pre-exposure prophylaxis (prep) will start next year. it is planned ... survey finds good knowledge of prep in europe and a considerable amount of unsupported informal prep use prep gus cairns | 01 december 2016 a large survey of knowledge and use of pre-exposure prophylaxis (prep) in europe released its preliminary results on world aids day. the flash! prep in europe survey found high, though varying levels ... there may be fewer people living with undiagnosed hiv in the uk than previously thought epidemiology and behaviour roger pebody | 01 december 2016 public health england’s estimate of the number of people who have hiv without being aware of it has been lowered, for the second year running. however, this does not necessarily reflect an ... cdc releases new data on hiv diagnosis and prevalence in the united states epidemiology liz highleyman | 30 november 2016 in advance of world aids day the us centers for disease control and prevention (cdc) released its latest report on recently diagnosed hiv infections in the united states. the new hiv surveillance report, which ... more news from aidsmap editor's picks from other sources viral load hiv viral load testing capacities progress, require global support, multiple partners to reach 90-90-90 goals science speaks | 9 hours ago hepatitis c symptoms and diagnosis first who prequalified hepatitis c rapid test opens the door to expanded treatment world health organization | 05 december 2016 prep israeli health ministry slammed for 'dragging feet' on new hiv drug israel hayom | 05 december 2016 experiences of stigma israel: hiv infected bodies are being segregated and covered in concrete by health officials pink news | 05 december 2016 epidemiology and behaviour why over 45s are at risk of sexually transmitted infections – new findings the conversation | 05 december 2016 circumcision male circumcision in uganda will only improve if local beliefs are considered the conversation | 05 december 2016 prep response to nhs england announcement on prep proud study | 05 december 2016 hepatitis c treatment hepatitis c drugs australia's most expensive, cost taxpayers $1 billion in four months abc online | 05 december 2016 drug policy and policing the philippines: no country for poor men bbc | 05 december 2016 relationships and feelings why male couples should think about hiv in their relationships the conversation | 05 december 2016 prep prep in the uk: terms and conditions will apply incidence 0 | 05 december 2016 prep questions about the prep implementation study greg owen (blog) | 05 december 2016 more editor's picks e-atlas algeria find news, resources and services from algeria 4 services1 news articles58 editors' picks15 resources or select a country from the list below afghanistan Åland islands albania algeria american samoa andorra angola anguilla antigua and barbuda argentina armenia aruba australia austria azerbaijan bahamas bahrain bangladesh barbados belarus belgium belize benin bermuda bhutan bolivia bosnia and herzegovina botswana brazil brunei darussalam bulgaria burkina faso burma burundi cambodia cameroon canada cape verde cayman islands central african republic chad chile china and hong kong christmas island colombia comoros congo congo, the democratic republic of the cook islands costa rica côte d'ivoire croatia cuba cyprus czech republic denmark djibouti dominica dominican republic ecuador egypt el salvador equatorial guinea eritrea estonia ethiopia falkland islands (malvinas) faroe islands fiji finland france french guiana french polynesia gabon gambia georgia germany ghana gibraltar greece greenland grenada guadeloupe guam guatemala guinea guinea-bissau guyana haiti honduras hungary iceland india indonesia iran, islamic republic of iraq ireland, republic of israel italy jamaica japan jordan kazakhstan kenya kiribati korea, democratic people's republic of korea, republic of kosovo kuwait kyrgyzstan lao people's democratic republic latvia lebanon lesotho liberia libyan arab jamahiriya liechtenstein lithuania luxembourg macao macedonia, the former yugoslav republic of madagascar malawi malaysia maldives mali malta marshall islands martinique mauritania mauritius mayotte mexico micronesia, federated states of moldova (republic of) monaco mongolia montenegro montserrat morocco mozambique namibia nauru nepal netherlands netherlands antilles new caledonia new zealand nicaragua niger nigeria niue norfolk island northern mariana islands norway oman pakistan palau palestinian territory, occupied panama papua new guinea paraguay peru philippines poland portugal puerto rico qatar réunion romania russian federation rwanda saint barthélemy saint kitts and nevis saint lucia saint martin saint pierre and miquelon saint vincent and the grenadines samoa san marino sao tome and principe saudi arabia senegal serbia seychelles sierra leone singapore slovakia slovenia solomon islands somalia south africa south sudan spain sri lanka sudan suriname svalbard and jan mayen swaziland sweden switzerland syrian arab republic tahiti - french polynesia taiwan tajikistan tanzania thailand timor-leste togo tokelau tonga trinidad and tobago tunisia turkey turkmenistan turks and caicos islands tuvalu uganda ukraine united arab emirates united kingdom united states uruguay uzbekistan vanuatu venezuela viet nam virgin islands, british virgin islands, u.s. wallis and futuna western sahara yemen zambia zimbabwe a to z of topics access to medicines and treatment achieving the 90-90-90 target activism adherence africans in the uk ageing and hiv alcohol bad science and bogus treatments behaviour change interventions bone problems cancer cardiovascular disease cd4 count changing treatment child developmental issues circumcision clinical trials combatting stigma complementary therapies conception condoms and lubricant confidentiality, consent and medical ethics contraception delivery of care diabetes diagnosing children disclosure and children discrimination and the law drug interactions and pharmacokinetics drug policy and policing drug-resistant tb employment end-of-life issues epidemiology epidemiology and behaviour exercise experiences of stigma families and children finance and funding finding support global health initiatives harm reduction health monitoring health monitoring in resource-limited settings health problems health services and systems healthy living hepatitis a hepatitis and hiv hepatitis b hepatitis c hepatitis c symptoms and diagnosis hepatitis c transmission and prevention hepatitis c treatment hepatitis c treatment side-effects history of hiv and aids hiv and criminal law hiv and sex hiv in children hiv prevention policy hiv testing hiv treatment hiv treatment in children how hiv causes disease how hiv works how transmission occurs human rights immigration immunisations infant feeding infectiousness and treatment as prevention kidney problems lipodystrophy living well with a low cd4 count low and theoretical transmission risks malaria malnutrition medical procedures and other blood-borne exposure men who have sex with men (msm) mental and emotional health mental and emotional health microbicides migrants money, benefits and housing neurological and cognitive problems new and experimental hepatitis c treatment new and experimental hiv treatments nutrition opportunistic infections other tests outcomes and prognosis palliative care people and personal stories people who inject drugs pep pharmaceutical industry policy populations prep prevention of mother-to-child transmission prisoners promoting hiv testing recreational drug use relationships and feelings religion and faith reproductive health resistance retention and linkage to care safer sex sex workers sexual transmission sexually transmitted infections side-effects sleep smoking social and legal issues spermwashing starting treatment structural factors support for families and children taking an hiv test task shifting tb diagnosis tb prevention tb services tb symptoms tb transmission tb treatment tb vaccine telling people you have hiv testing and health monitoring testing policies and guidelines the search for a cure transgender people transmission and prevention travel treatment for women treatment guidelines treatment interruptions treatment-experienced people tuberculosis and hiv types of hiv tests uk health services vaccines viral load what is aids? what is hiv? women young people a to z of drugs abacavir (ziagen) atazanavir (reyataz) atripla darunavir (prezista) descovy dolutegravir (tivicay) efavirenz (sustiva) elvitegravir (vitekta) emtricitabine (ftc, emtriva) etravirine (intelence) eviplera evotaz fosamprenavir (telzir, lexiva) genvoya kivexa (abacavir/3tc) lamivudine (3tc, epivir) lopinavir/ritonavir (kaletra) maraviroc (celsentri) nevirapine (viramune) odefsey raltegravir (isentress) rezolsta rilpivirine (edurant) ritonavir (norvir) stribild tenofovir (viread) triumeq truvada (tenofovir/ftc) zidovudine (azt, retrovir) nam blog start here – our factsheets on hiv prevention and treatment 10 hours ago world aids day 25 november 2016 launch of about hiv / pro vich website 23 october 2016 european delays on hiv prevention drug endanger gay men and others at risk of hiv 18 october 2016 more the information standard certified member nam’s information is intended to support, rather than replace, consultation with a healthcare professional. talk to your doctor or another member of your healthcare team for advice tailored to your situation. aidsmap news feeds subscribe to our news feeds email updates get the latest hiv news delivered to your inbox share/bookmark this page   facebook   twitter   stumbleupon   linkedin   reddit   digg   delicious   technorati   g bookmarks   y! bookmarks --> nam publications registered office: acorn house, 314-320 gray’s inn road, london, wc1x 8dp company limited by guarantee. registered in england & wales, number: 2707596 registered charity, number: 1011220 © nam publications, 2016. all rights reserved. nam is not responsible for the content of external websites. sitemapaccessibility & terms of useprivacy & cookiesfeedbackcontact usmobile version--> sign the community consensus statement on access to hiv treatment and its use for prevention more community consensus statement on access to hiv treatment and its use for prevention together, we can make it happen we can end hiv soon if people have equal access to hiv drugs as treatment and as prep, and have free choice over whether to take them. launched today, the community consensus statement is a basic set of principles aimed at making sure that happens. read it sign it share it the community consensus statement is a joint initiative of avac, eatg, msmgf, gnp+, hiv i-base, the international hiv/aids alliance, itpc and nam/aidsmap close this content was checked for accuracy at the time it was written. it may have been superseded by more recent developments. nam recommends checking whether this is the most current information when making decisions that may affect your health. nam’s information is intended to support, rather than replace, consultation with a healthcare professional. talk to your doctor or another member of your healthcare team for advice tailored to your situation.


Here you find all texts from your page as Google (googlebot) and others search engines seen it.

Words density analysis:

Numbers of all words: 3301

One word

Two words phrases

Three words phrases

and - 5.54% (183)
the - 3.3% (109)
hiv - 3.18% (105)
men - 2.7% (89)
for - 1.67% (55)
our - 1.51% (50)
treatment - 1.42% (47)
new - 1.3% (43)
pro - 1.06% (35)
health - 1.03% (34)
are - 0.82% (27)
out - 0.82% (27)
drug - 0.82% (27)
2016 - 0.79% (26)
hepatitis - 0.73% (24)
people - 0.7% (23)
prep - 0.7% (23)
even - 0.7% (23)
nam - 0.67% (22)
aids - 0.67% (22)
prevention - 0.67% (22)
news - 0.64% (21)
with - 0.61% (20)
you - 0.58% (19)
december - 0.55% (18)
test - 0.51% (17)
use - 0.48% (16)
child - 0.48% (16)
care - 0.48% (16)
public - 0.48% (16)
have - 0.48% (16)
service - 0.48% (16)
support - 0.45% (15)
drugs - 0.45% (15)
about - 0.45% (15)
all - 0.45% (15)
transmission - 0.45% (15)
sex - 0.42% (14)
island - 0.39% (13)
who - 0.39% (13)
information - 0.39% (13)
can - 0.39% (13)
over - 0.39% (13)
find - 0.39% (13)
services - 0.39% (13)
how - 0.36% (12)
republic - 0.36% (12)
children - 0.36% (12)
one - 0.36% (12)
factsheet - 0.36% (12)
more - 0.33% (11)
here - 0.33% (11)
islands - 0.33% (11)
viral - 0.33% (11)
your - 0.33% (11)
sources - 0.3% (10)
factsheets - 0.3% (10)
infection - 0.3% (10)
not - 0.3% (10)
other - 0.3% (10)
end - 0.3% (10)
... - 0.3% (10)
sure - 0.3% (10)
topic - 0.27% (9)
living - 0.27% (9)
this - 0.27% (9)
mental - 0.27% (9)
its - 0.27% (9)
key - 0.27% (9)
europe - 0.24% (8)
resources - 0.24% (8)
policy - 0.24% (8)
get - 0.24% (8)
count - 0.24% (8)
testing - 0.24% (8)
issues - 0.24% (8)
england - 0.24% (8)
trial - 0.24% (8)
adherence - 0.24% (8)
world - 0.24% (8)
monitoring - 0.24% (8)
has - 0.24% (8)
problems - 0.24% (8)
page - 0.24% (8)
united - 0.24% (8)
website - 0.21% (7)
search - 0.21% (7)
states - 0.21% (7)
start - 0.21% (7)
low - 0.21% (7)
sexual - 0.21% (7)
from - 0.21% (7)
guide - 0.21% (7)
antiretroviral - 0.21% (7)
launch - 0.21% (7)
epidemiology - 0.21% (7)
harm - 0.21% (7)
rica - 0.21% (7)
what - 0.21% (7)
side-effects - 0.18% (6)
behaviour - 0.18% (6)
exposure - 0.18% (6)
saint - 0.18% (6)
access - 0.18% (6)
topics - 0.18% (6)
need - 0.18% (6)
series - 0.18% (6)
infections - 0.18% (6)
ago - 0.18% (6)
conference - 0.18% (6)
sign - 0.18% (6)
day - 0.18% (6)
just - 0.18% (6)
san - 0.18% (6)
blog - 0.18% (6)
liver - 0.18% (6)
cure - 0.18% (6)
view - 0.18% (6)
stigma - 0.15% (5)
was - 0.15% (5)
nhs - 0.15% (5)
law - 0.15% (5)
high - 0.15% (5)
launched - 0.15% (5)
vich - 0.15% (5)
now - 0.15% (5)
read - 0.15% (5)
diagnosis - 0.15% (5)
time - 0.15% (5)
that - 0.15% (5)
aidsmap - 0.15% (5)
list - 0.15% (5)
disease - 0.15% (5)
but - 0.15% (5)
hours - 0.15% (5)
arab - 0.15% (5)
among - 0.15% (5)
take - 0.15% (5)
chart - 0.15% (5)
will - 0.15% (5)
most - 0.15% (5)
healthcare - 0.15% (5)
may - 0.15% (5)
year - 0.15% (5)
some - 0.15% (5)
transmitted - 0.15% (5)
families - 0.12% (4)
emotional - 0.12% (4)
european - 0.12% (4)
vaccine - 0.12% (4)
each - 0.12% (4)
symptoms - 0.12% (4)
online - 0.12% (4)
their - 0.12% (4)
than - 0.12% (4)
november - 0.12% (4)
french - 0.12% (4)
relationships - 0.12% (4)
pre-exposure - 0.12% (4)
october - 0.12% (4)
gus - 0.12% (4)
prophylaxis - 0.12% (4)
make - 0.12% (4)
diagnosed - 0.12% (4)
know - 0.12% (4)
report - 0.12% (4)
hiv? - 0.12% (4)
israel - 0.12% (4)
recent - 0.12% (4)
risk - 0.12% (4)
(prep) - 0.12% (4)
develop - 0.12% (4)
release - 0.12% (4)
global - 0.12% (4)
guinea - 0.12% (4)
share - 0.12% (4)
inject - 0.12% (4)
community - 0.12% (4)
consensus - 0.12% (4)
latest - 0.12% (4)
statement - 0.12% (4)
section - 0.12% (4)
nutrition - 0.12% (4)
women - 0.12% (4)
treatments - 0.12% (4)
circumcision - 0.12% (4)
change - 0.12% (4)
liz - 0.12% (4)
medical - 0.12% (4)
basic - 0.09% (3)
only - 0.09% (3)
georgia - 0.09% (3)
mali - 0.09% (3)
booklet - 0.09% (3)
food - 0.09% (3)
oman - 0.09% (3)
africa - 0.09% (3)
dosing, - 0.09% (3)
formulation, - 0.09% (3)
types - 0.09% (3)
union, - 0.09% (3)
member - 0.09% (3)
licensed - 0.09% (3)
major - 0.09% (3)
2017 - 0.09% (3)
registered - 0.09% (3)
overview - 0.09% (3)
anti-hiv - 0.09% (3)
inn - 0.09% (3)
reference - 0.09% (3)
well - 0.09% (3)
initiative - 0.09% (3)
one-page - 0.09% (3)
meeting - 0.09% (3)
story - 0.09% (3)
cd4 - 0.09% (3)
providing - 0.09% (3)
democratic - 0.09% (3)
place - 0.09% (3)
glasgow - 0.09% (3)
covering - 0.09% (3)
factsheets, - 0.09% (3)
survey - 0.09% (3)
knowledge - 0.09% (3)
number - 0.09% (3)
relaunched - 0.09% (3)
electronic - 0.09% (3)
– - 0.09% (3)
highleyman - 0.09% (3)
picks - 0.09% (3)
load - 0.09% (3)
clinic - 0.09% (3)
support, - 0.09% (3)
confidentiality - 0.09% (3)
aspect - 0.09% (3)
contact - 0.09% (3)
conversation - 0.09% (3)
using - 0.09% (3)
uganda - 0.09% (3)
kazakh - 0.09% (3)
country - 0.09% (3)
restrictions. - 0.09% (3)
algeria - 0.09% (3)
armenia - 0.09% (3)
care. - 0.09% (3)
nam’s - 0.09% (3)
aids. - 0.09% (3)
hcv - 0.09% (3)
study - 0.09% (3)
russian - 0.09% (3)
health. - 0.09% (3)
gay - 0.09% (3)
hiv. - 0.09% (3)
features - 0.09% (3)
sexually - 0.09% (3)
taking - 0.09% (3)
research - 0.09% (3)
guidelines - 0.09% (3)
finding - 0.09% (3)
found - 0.09% (3)
interruptions - 0.09% (3)
policing - 0.09% (3)
target - 0.09% (3)
feelings - 0.09% (3)
feeds - 0.09% (3)
section. - 0.09% (3)
questions - 0.09% (3)
virus - 0.09% (3)
90-90-90 - 0.09% (3)
aids? - 0.09% (3)
reduction - 0.09% (3)
rights - 0.09% (3)
works - 0.09% (3)
science - 0.09% (3)
lives - 0.09% (3)
bad - 0.09% (3)
--> - 0.09% (3)
diego - 0.09% (3)
experiences - 0.09% (3)
syringe - 0.09% (3)
experimental - 0.09% (3)
changing - 0.09% (3)
glasgow, - 0.06% (2)
why - 0.06% (2)
catch - 0.06% (2)
african - 0.06% (2)
basics - 0.06% (2)
news, - 0.06% (2)
samoa - 0.06% (2)
male - 0.06% (2)
genotypes - 0.06% (2)
cost - 0.06% (2)
update - 0.06% (2)
terms - 0.06% (2)
greg - 0.06% (2)
select - 0.06% (2)
australia - 0.06% (2)
being - 0.06% (2)
answers - 0.06% (2)
resistance - 0.06% (2)
infectiousness - 0.06% (2)
bogus - 0.06% (2)
increased - 0.06% (2)
past - 0.06% (2)
prognosis - 0.06% (2)
outcomes - 0.06% (2)
treatment-experienced - 0.06% (2)
prevalence - 0.06% (2)
cairns - 0.06% (2)
england, - 0.06% (2)
pharmacokinetics - 0.06% (2)
editor's - 0.06% (2)
today - 0.06% (2)
implementation - 0.06% (2)
interactions - 0.06% (2)
starting - 0.06% (2)
released - 0.06% (2)
though - 0.06% (2)
been - 0.06% (2)
way - 0.06% (2)
cdc - 0.06% (2)
might - 0.06% (2)
british - 0.06% (2)
healthy - 0.06% (2)
congo - 0.06% (2)
third - 0.06% (2)
consultation - 0.06% (2)
professional. - 0.06% (2)
talk - 0.06% (2)
doctor - 0.06% (2)
another - 0.06% (2)
team - 0.06% (2)
advice - 0.06% (2)
tailored - 0.06% (2)
situation. - 0.06% (2)
still - 0.06% (2)
bookmarks - 0.06% (2)
publications - 0.06% (2)
up, - 0.06% (2)
rather - 0.06% (2)
limited - 0.06% (2)
number: - 0.06% (2)
content - 0.06% (2)
states: - 0.06% (2)
home - 0.06% (2)
happen - 0.06% (2)
equal - 0.06% (2)
whether - 0.06% (2)
set - 0.06% (2)
making - 0.06% (2)
sharing - 0.06% (2)
current - 0.06% (2)
replace, - 0.06% (2)
intended - 0.06% (2)
cook - 0.06% (2)
pill - 0.06% (2)
bisexual - 0.06% (2)
dominica - 0.06% (2)
recently - 0.06% (2)
polynesia - 0.06% (2)
rising - 0.06% (2)
korea, - 0.06% (2)
people's - 0.06% (2)
intensive - 0.06% (2)
netherlands - 0.06% (2)
niger - 0.06% (2)
philippines - 0.06% (2)
romania - 0.06% (2)
martin - 0.06% (2)
needles - 0.06% (2)
south - 0.06% (2)
boosts - 0.06% (2)
sudan - 0.06% (2)
jan - 0.06% (2)
virgin - 0.06% (2)
islands, - 0.06% (2)
tests - 0.06% (2)
time" - 0.06% (2)
abacavir - 0.06% (2)
ritonavir - 0.06% (2)
tenofovir - 0.06% (2)
"real - 0.06% (2)
standard - 0.06% (2)
occurs - 0.06% (2)
central - 0.06% (2)
procedures - 0.06% (2)
contraception - 0.06% (2)
comprehensive - 0.06% (2)
activism - 0.06% (2)
trials - 0.06% (2)
clinical - 0.06% (2)
palliative - 0.06% (2)
tools - 0.06% (2)
shifting - 0.06% (2)
decisions - 0.06% (2)
task - 0.06% (2)
delivery - 0.06% (2)
systems - 0.06% (2)
armenian - 0.06% (2)
georgian - 0.06% (2)
industry - 0.06% (2)
german - 0.06% (2)
italian - 0.06% (2)
safer - 0.06% (2)
somali - 0.06% (2)
thai - 0.06% (2)
ukrainian - 0.06% (2)
e-atlas - 0.06% (2)
across - 0.06% (2)
drug-resistant - 0.06% (2)
tuberculosis - 0.06% (2)
reproductive - 0.06% (2)
developmental - 0.06% (2)
resourcesan - 0.06% (2)
pharmaceutical - 0.06% (2)
booklets - 0.06% (2)
diagnosing - 0.06% (2)
neurological - 0.06% (2)
recreational - 0.06% (2)
causes - 0.06% (2)
smoking - 0.06% (2)
complementary - 0.06% (2)
therapies - 0.06% (2)
immunisations - 0.06% (2)
sleep - 0.06% (2)
malnutrition - 0.06% (2)
lipodystrophy - 0.06% (2)
bone - 0.06% (2)
cognitive - 0.06% (2)
full - 0.06% (2)
malaria - 0.06% (2)
finance - 0.06% (2)
diabetes - 0.06% (2)
cardiovascular - 0.06% (2)
cancer - 0.06% (2)
opportunistic - 0.06% (2)
ageing - 0.06% (2)
kidney - 0.06% (2)
achieving - 0.06% (2)
linkage - 0.06% (2)
retention - 0.06% (2)
medicines - 0.06% (2)
initiatives - 0.06% (2)
next - 0.06% (2)
funding - 0.06% (2)
countries - 0.06% (2)
disclosure - 0.06% (2)
blood-borne - 0.06% (2)
structural - 0.06% (2)
money, - 0.06% (2)
immigration - 0.06% (2)
criminal - 0.06% (2)
announced - 0.06% (2)
telling - 0.06% (2)
legal - 0.06% (2)
social - 0.06% (2)
factors - 0.06% (2)
planned - 0.06% (2)
three - 0.06% (2)
years - 0.06% (2)
million - 0.06% (2)
spermwashing - 0.06% (2)
pagefind - 0.06% (2)
vaccines - 0.06% (2)
available - 0.06% (2)
through - 0.06% (2)
microbicides - 0.06% (2)
interventions - 0.06% (2)
pep - 0.06% (2)
lubricant - 0.06% (2)
good - 0.06% (2)
rates - 0.06% (2)
condoms - 0.06% (2)
exercise - 0.06% (2)
risks - 0.06% (2)
theoretical - 0.06% (2)
benefits - 0.06% (2)
health.visit - 0.06% (2)
conception - 0.06% (2)
confidentiality, - 0.06% (2)
feeding - 0.06% (2)
infant - 0.06% (2)
mother-to-child - 0.06% (2)
stories - 0.06% (2)
personal - 0.06% (2)
history - 0.06% (2)
combatting - 0.06% (2)
human - 0.06% (2)
discrimination - 0.06% (2)
end-of-life - 0.06% (2)
travel - 0.06% (2)
ethics - 0.06% (2)
consent - 0.06% (2)
faith - 0.06% (2)
want - 0.06% (2)
religion - 0.06% (2)
employment - 0.06% (2)
design - 0.06% (2)
important - 0.06% (2)
prevention, - 0.06% (2)
care.each - 0.06% (2)
housing - 0.06% (2)
gives - 0.06% (2)
brief - 0.06% (2)
aspects - 0.06% (2)
topic, - 0.06% (2)
easy-to-understand - 0.06% (2)
individuals - 0.06% (2)
alcohol - 0.06% (2)
december 2016 - 0.55% (18)
in the - 0.48% (16)
hepatitis c - 0.48% (16)
05 december - 0.45% (15)
of hiv - 0.33% (11)
hiv and - 0.3% (10)
hiv treatment - 0.3% (10)
of the - 0.27% (9)
about hiv - 0.24% (8)
hiv prevention - 0.21% (7)
hiv test - 0.21% (7)
republic of - 0.21% (7)
hiv in - 0.21% (7)
and hiv - 0.21% (7)
and treatment - 0.18% (6)
united states - 0.18% (6)
have hiv - 0.18% (6)
the uk - 0.18% (6)
and children - 0.18% (6)
series of - 0.18% (6)
people who - 0.18% (6)
what is - 0.18% (6)
out the - 0.15% (5)
hiv factsheets - 0.15% (5)
nhs england - 0.15% (5)
and prevention - 0.15% (5)
hours ago - 0.15% (5)
health monitoring - 0.15% (5)
drugs chart - 0.15% (5)
search for - 0.15% (5)
pro vich - 0.15% (5)
and the - 0.15% (5)
with hiv - 0.15% (5)
children | - 0.15% (5)
living with - 0.15% (5)
access to - 0.15% (5)
c treatment - 0.15% (5)
to your - 0.15% (5)
and aids - 0.12% (4)
emotional health - 0.12% (4)
and in - 0.12% (4)
how hiv - 0.12% (4)
mental and - 0.12% (4)
pre-exposure prophylaxis - 0.12% (4)
prep in - 0.12% (4)
and emotional - 0.12% (4)
health services - 0.12% (4)
with a - 0.12% (4)
the most - 0.12% (4)
with information - 0.12% (4)
and behaviour - 0.12% (4)
in children - 0.12% (4)
antiretroviral drugs - 0.12% (4)
families and - 0.12% (4)
hepatitis a - 0.12% (4)
consensus statement - 0.12% (4)
prophylaxis (prep) - 0.12% (4)
of people - 0.12% (4)
this section - 0.12% (4)
hiv testing - 0.12% (4)
2016 prep - 0.12% (4)
world aids - 0.12% (4)
in this - 0.12% (4)
aids day - 0.12% (4)
transmission and - 0.12% (4)
on hiv - 0.12% (4)
epidemiology and - 0.12% (4)
hiv drugs - 0.12% (4)
inject drugs - 0.12% (4)
& aids - 0.12% (4)
who inject - 0.12% (4)
community consensus - 0.12% (4)
treatment | - 0.12% (4)
you have - 0.12% (4)
cd4 count - 0.09% (3)
about the - 0.09% (3)
conversation | - 0.09% (3)
and experimental - 0.09% (3)
and other - 0.09% (3)
men who - 0.09% (3)
people living - 0.09% (3)
one-page reference - 0.09% (3)
to support - 0.09% (3)
the community - 0.09% (3)
and care. - 0.09% (3)
our news - 0.09% (3)
nam blog - 0.09% (3)
reference guide - 0.09% (3)
october 2016 - 0.09% (3)
and food - 0.09% (3)
key side-effects - 0.09% (3)
formulation, dosing, - 0.09% (3)
the conversation - 0.09% (3)
union, with - 0.09% (3)
the european - 0.09% (3)
use in - 0.09% (3)
licensed for - 0.09% (3)
anti-hiv drugs - 0.09% (3)
to the - 0.09% (3)
information on - 0.09% (3)
for use - 0.09% (3)
sexually transmitted - 0.09% (3)
major new - 0.09% (3)
nam has - 0.09% (3)
some of - 0.09% (3)
overview of - 0.09% (3)
information for - 0.09% (3)
out more - 0.09% (3)
in our - 0.09% (3)
adherence in - 0.09% (3)
the hiv - 0.09% (3)
over the - 0.09% (3)
of antiretroviral - 0.09% (3)
electronic monitoring - 0.09% (3)
the united - 0.09% (3)
liver meeting - 0.09% (3)
highleyman | - 0.09% (3)
who have - 0.09% (3)
in europe - 0.09% (3)
guide to - 0.09% (3)
dosing, key - 0.09% (3)
the anti-hiv - 0.09% (3)
drugs licensed - 0.09% (3)
an hiv - 0.09% (3)
of stigma - 0.09% (3)
european union, - 0.09% (3)
on formulation, - 0.09% (3)
side-effects and - 0.09% (3)
23 october - 0.09% (3)
food restrictions. - 0.09% (3)
viral load - 0.09% (3)
its series - 0.09% (3)
factsheets, covering - 0.09% (3)
for the - 0.09% (3)
vich website - 0.09% (3)
problems | - 0.09% (3)
just relaunched - 0.09% (3)
new and - 0.09% (3)
transmitted infections - 0.09% (3)
and feelings - 0.09% (3)
transmission | - 0.09% (3)
treatment interruptions - 0.09% (3)
antiretroviral adherence - 0.09% (3)
this section. - 0.09% (3)
experiences of - 0.09% (3)
is aids? - 0.09% (3)
is hiv? - 0.09% (3)
| treatment - 0.09% (3)
monitoring of - 0.09% (3)
policy and - 0.09% (3)
men in - 0.09% (3)
| drug - 0.09% (3)
for prevention - 0.09% (3)
san diego - 0.09% (3)
news feeds - 0.09% (3)
harm reduction - 0.09% (3)
care | - 0.09% (3)
and bisexual - 0.06% (2)
democratic republic - 0.06% (2)
virgin islands, - 0.06% (2)
from other - 0.06% (2)
health problems - 0.06% (2)
the 90-90-90 - 0.06% (2)
and lubricant - 0.06% (2)
and funding - 0.06% (2)
end-of-life issues - 0.06% (2)
interactions and - 0.06% (2)
is rising - 0.06% (2)
and medical - 0.06% (2)
confidentiality, consent - 0.06% (2)
complementary therapies - 0.06% (2)
science and - 0.06% (2)
child developmental - 0.06% (2)
changing treatment - 0.06% (2)
among gay - 0.06% (2)
cardiovascular disease - 0.06% (2)
behaviour change - 0.06% (2)
bogus treatments - 0.06% (2)
risk of - 0.06% (2)
editor's picks - 0.06% (2)
conference news - 0.06% (2)
europe and - 0.06% (2)
taking and - 0.06% (2)
need for - 0.06% (2)
intensive adherence - 0.06% (2)
might have - 0.06% (2)
of treatment - 0.06% (2)
is not - 0.06% (2)
have an - 0.06% (2)
sex with - 0.06% (2)
new prep - 0.06% (2)
trial for - 0.06% (2)
gus cairns - 0.06% (2)
a major - 0.06% (2)
prep gus - 0.06% (2)
catch up - 0.06% (2)
cairns | - 0.06% (2)
01 december - 0.06% (2)
of pre-exposure - 0.06% (2)
you might - 0.06% (2)
released its - 0.06% (2)
public health - 0.06% (2)
how is - 0.06% (2)
diagnosed hiv - 0.06% (2)
new hiv - 0.06% (2)
hepatitis and - 0.06% (2)
hiv research - 0.06% (2)
symptoms and - 0.06% (2)
on recent - 0.06% (2)
finding support - 0.06% (2)
virus infection - 0.06% (2)
hiv hepatitis - 0.06% (2)
talk to - 0.06% (2)
pill taking - 0.06% (2)
start here - 0.06% (2)
time" boosts - 0.06% (2)
25 november - 0.06% (2)
of about - 0.06% (2)
website 23 - 0.06% (2)
in "real - 0.06% (2)
nam’s information - 0.06% (2)
is intended - 0.06% (2)
to support, - 0.06% (2)
rather than - 0.06% (2)
replace, consultation - 0.06% (2)
healthcare professional. - 0.06% (2)
your doctor - 0.06% (2)
treatment-experienced people - 0.06% (2)
or another - 0.06% (2)
member of - 0.06% (2)
your healthcare - 0.06% (2)
team for - 0.06% (2)
advice tailored - 0.06% (2)
still share - 0.06% (2)
nam publications - 0.06% (2)
third of - 0.06% (2)
statement on - 0.06% (2)
and its - 0.06% (2)
use for - 0.06% (2)
we can - 0.06% (2)
use up, - 0.06% (2)
syringe service - 0.06% (2)
tuberculosis and - 0.06% (2)
testing and - 0.06% (2)
c symptoms - 0.06% (2)
have sex - 0.06% (2)
and diagnosis - 0.06% (2)
history of - 0.06% (2)
and criminal - 0.06% (2)
"real time" - 0.06% (2)
transmission occurs - 0.06% (2)
human rights - 0.06% (2)
infant feeding - 0.06% (2)
and theoretical - 0.06% (2)
transmission risks - 0.06% (2)
medical procedures - 0.06% (2)
adherence support - 0.06% (2)
blood-borne exposure - 0.06% (2)
for intensive - 0.06% (2)
with men - 0.06% (2)
support for - 0.06% (2)
benefits and - 0.06% (2)
and cognitive - 0.06% (2)
and need - 0.06% (2)
hiv treatments - 0.06% (2)
and prognosis - 0.06% (2)
palliative care - 0.06% (2)
people and - 0.06% (2)
personal stories - 0.06% (2)
prevention of - 0.06% (2)
mother-to-child transmission - 0.06% (2)
recreational drug - 0.06% (2)
religion and - 0.06% (2)
starting treatment - 0.06% (2)
structural factors - 0.06% (2)
boosts pill - 0.06% (2)
has increased - 0.06% (2)
found out - 0.06% (2)
issues | - 0.06% (2)
for families - 0.06% (2)
developmental issues - 0.06% (2)
diagnosing children - 0.06% (2)
disclosure and - 0.06% (2)
to get - 0.06% (2)
of mother-to-child - 0.06% (2)
chart a - 0.06% (2)
| hepatitis - 0.06% (2)
and personal - 0.06% (2)
combatting stigma - 0.06% (2)
the law - 0.06% (2)
discrimination and - 0.06% (2)
stigma | - 0.06% (2)
medical ethics - 0.06% (2)
a series - 0.06% (2)
consent and - 0.06% (2)
and faith - 0.06% (2)
and housing - 0.06% (2)
hiv services - 0.06% (2)
for hiv - 0.06% (2)
services in - 0.06% (2)
– our - 0.06% (2)
factsheets on - 0.06% (2)
money, benefits - 0.06% (2)
10 hours - 0.06% (2)
aidsmap hiv - 0.06% (2)
criminal law - 0.06% (2)
day 25 - 0.06% (2)
tb vaccine - 0.06% (2)
list of - 0.06% (2)
and legal - 0.06% (2)
drug use - 0.06% (2)
90-90-90 target - 0.06% (2)
health | - 0.06% (2)
opportunistic infections - 0.06% (2)
neurological and - 0.06% (2)
cognitive problems - 0.06% (2)
achieving the - 0.06% (2)
hiv works - 0.06% (2)
linkage to - 0.06% (2)
retention and - 0.06% (2)
causes disease - 0.06% (2)
healthy living - 0.06% (2)
medicines and - 0.06% (2)
global health - 0.06% (2)
living well - 0.06% (2)
for people - 0.06% (2)
finance and - 0.06% (2)
low cd4 - 0.06% (2)
full list - 0.06% (2)
of topics - 0.06% (2)
clinical trials - 0.06% (2)
task shifting - 0.06% (2)
delivery of - 0.06% (2)
and systems - 0.06% (2)
safer sex - 0.06% (2)
and sex - 0.06% (2)
drug-resistant tb - 0.06% (2)
tb diagnosis - 0.06% (2)
tb prevention - 0.06% (2)
people you - 0.06% (2)
prevention policy - 0.06% (2)
and health - 0.06% (2)
on the - 0.06% (2)
treatment as - 0.06% (2)
is planned - 0.06% (2)
infectiousness and - 0.06% (2)
more about - 0.06% (2)
the trial - 0.06% (2)
and bogus - 0.06% (2)
bad science - 0.06% (2)
the search - 0.06% (2)
outcomes and - 0.06% (2)
the liver - 0.06% (2)
experimental hiv - 0.06% (2)
the latest - 0.06% (2)
features a - 0.06% (2)
for women - 0.06% (2)
that a - 0.06% (2)
states: syringe - 0.06% (2)
service use - 0.06% (2)
up, but - 0.06% (2)
a third - 0.06% (2)
and pharmacokinetics - 0.06% (2)
drugs still - 0.06% (2)
share needles - 0.06% (2)
drug interactions - 0.06% (2)
11 hours - 0.06% (2)
kidney problems - 0.06% (2)
the past - 0.06% (2)
treatment guidelines - 0.06% (2)
monitoring hiv - 0.06% (2)
prevention | - 0.06% (2)
has announced - 0.06% (2)
| epidemiology - 0.06% (2)
the key - 0.06% (2)
how you - 0.06% (2)
about us - 0.06% (2)
design of - 0.06% (2)
change interventions - 0.06% (2)
condoms and - 0.06% (2)
theoretical transmission - 0.06% (2)
important topics - 0.06% (2)
in hiv - 0.06% (2)
prevention, treatment - 0.06% (2)
and care.each - 0.06% (2)
factsheet gives - 0.06% (2)
a brief - 0.06% (2)
low and - 0.06% (2)
aspects of - 0.06% (2)
how transmission - 0.06% (2)
a topic, - 0.06% (2)
providing easy-to-understand - 0.06% (2)
other blood-borne - 0.06% (2)
individuals who - 0.06% (2)
want to - 0.06% (2)
take care - 0.06% (2)
of their - 0.06% (2)
health.visit our - 0.06% (2)
factsheets pagefind - 0.06% (2)
procedures and - 0.06% (2)
sexual transmission - 0.06% (2)
blog new - 0.06% (2)
prep trial - 0.06% (2)
for 2017 - 0.06% (2)
--> nam - 0.06% (2)
05 december 2016 - 0.45% (15)
| 05 december - 0.39% (13)
in the uk - 0.18% (6)
/ pro vich - 0.15% (5)
and emotional health - 0.12% (4)
transmission and prevention - 0.12% (4)
people who inject - 0.12% (4)
community consensus statement - 0.12% (4)
december 2016 prep - 0.12% (4)
in this section - 0.12% (4)
living with hiv - 0.12% (4)
hiv & aids - 0.12% (4)
epidemiology and behaviour - 0.12% (4)
hiv and aids - 0.12% (4)
mental and emotional - 0.12% (4)
who inject drugs - 0.12% (4)
families and children - 0.12% (4)
in the european - 0.09% (3)
on formulation, dosing, - 0.09% (3)
anti-hiv drugs licensed - 0.09% (3)
union, with information - 0.09% (3)
licensed for use - 0.09% (3)
hiv treatment and - 0.09% (3)
for use in - 0.09% (3)
the anti-hiv drugs - 0.09% (3)
the european union, - 0.09% (3)
with information on - 0.09% (3)
formulation, dosing, key - 0.09% (3)
has just relaunched - 0.09% (3)
key side-effects and - 0.09% (3)
antiretroviral adherence in - 0.09% (3)
its series of - 0.09% (3)
european union, with - 0.09% (3)
electronic monitoring of - 0.09% (3)
liz highleyman | - 0.09% (3)
in san diego - 0.09% (3)
people living with - 0.09% (3)
dosing, key side-effects - 0.09% (3)
information on formulation, - 0.09% (3)
use in the - 0.09% (3)
hiv factsheets, covering - 0.09% (3)
drugs licensed for - 0.09% (3)
in the united - 0.09% (3)
conversation | 05 - 0.09% (3)
relationships and feelings - 0.09% (3)
factsheets, covering some - 0.09% (3)
just relaunched its - 0.09% (3)
experiences of stigma - 0.09% (3)
series of hiv - 0.09% (3)
side-effects and food - 0.09% (3)
policy and policing - 0.09% (3)
the community consensus - 0.09% (3)
men in san - 0.09% (3)
what is hiv? - 0.09% (3)
some of the - 0.09% (3)
on hiv prevention - 0.09% (3)
of people who - 0.09% (3)
of antiretroviral adherence - 0.09% (3)
new and experimental - 0.09% (3)
on access to - 0.06% (2)
treatment hepatitis c - 0.06% (2)
its use for - 0.06% (2)
that a major - 0.06% (2)
access to medicines - 0.06% (2)
the 90-90-90 target - 0.06% (2)
statement is a - 0.06% (2)
hepatitis c symptoms - 0.06% (2)
consensus statement is - 0.06% (2)
ageing and hiv - 0.06% (2)
01 december 2016 - 0.06% (2)
of pre-exposure prophylaxis - 0.06% (2)
recreational drug use - 0.06% (2)
gus cairns | - 0.06% (2)
to your doctor - 0.06% (2)
team for advice - 0.06% (2)
of your healthcare - 0.06% (2)
virus infection is - 0.06% (2)
rising among gay - 0.06% (2)
and bisexual men - 0.06% (2)
or another member - 0.06% (2)
hepatitis c transmission - 0.06% (2)
new prep trial - 0.06% (2)
men who have - 0.06% (2)
healthcare professional. talk - 0.06% (2)
consultation with a - 0.06% (2)
rather than replace, - 0.06% (2)
intended to support, - 0.06% (2)
nam’s information is - 0.06% (2)
sex with men - 0.06% (2)
drug interactions and - 0.06% (2)
to hiv treatment - 0.06% (2)
and its use - 0.06% (2)
– our factsheets - 0.06% (2)
is intended to - 0.06% (2)
at risk of - 0.06% (2)
low and theoretical - 0.06% (2)
need for intensive - 0.06% (2)
aids day 25 - 0.06% (2)
and treatment 10 - 0.06% (2)
and health monitoring - 0.06% (2)
support, rather than - 0.06% (2)
and other blood-borne - 0.06% (2)
have sex with - 0.06% (2)
for families and - 0.06% (2)
and experimental hiv - 0.06% (2)
and personal stories - 0.06% (2)
retention and linkage - 0.06% (2)
how transmission occurs - 0.06% (2)
replace, consultation with - 0.06% (2)
religion and faith - 0.06% (2)
advice tailored to - 0.06% (2)
statement on access - 0.06% (2)
finance and funding - 0.06% (2)
hepatitis and hiv - 0.06% (2)
symptoms and diagnosis - 0.06% (2)
c treatment hepatitis - 0.06% (2)
history of hiv - 0.06% (2)
healthcare team for - 0.06% (2)
a healthcare professional. - 0.06% (2)
member of your - 0.06% (2)
and criminal law - 0.06% (2)
hiv and sex - 0.06% (2)
hiv in children - 0.06% (2)
hiv prevention policy - 0.06% (2)
doctor or another - 0.06% (2)
talk to your - 0.06% (2)
aidsmap hiv & - 0.06% (2)
prep trial for - 0.06% (2)
pill taking and - 0.06% (2)
a families and - 0.06% (2)
and legal issues - 0.06% (2)
telling people you - 0.06% (2)
hiv and criminal - 0.06% (2)
money, benefits and - 0.06% (2)
consent and medical - 0.06% (2)
and the law - 0.06% (2)
and hiv hepatitis - 0.06% (2)
hiv treatment in - 0.06% (2)
theoretical transmission risks - 0.06% (2)
in children | - 0.06% (2)
child developmental issues - 0.06% (2)
tuberculosis and hiv - 0.06% (2)
services and systems - 0.06% (2)
delivery of care - 0.06% (2)
global health initiatives - 0.06% (2)
medicines and treatment - 0.06% (2)
linkage to care - 0.06% (2)
behaviour change interventions - 0.06% (2)
other blood-borne exposure - 0.06% (2)
hiv causes disease - 0.06% (2)
is rising among - 0.06% (2)
but a third - 0.06% (2)
inject drugs still - 0.06% (2)
in "real time" - 0.06% (2)
boosts pill taking - 0.06% (2)
and need for - 0.06% (2)
intensive adherence support - 0.06% (2)
c virus infection - 0.06% (2)
gay and bisexual - 0.06% (2)
medical procedures and - 0.06% (2)
an hiv test - 0.06% (2)
treatment hiv treatment - 0.06% (2)
health monitoring hiv - 0.06% (2)
treatment for women - 0.06% (2)
outcomes and prognosis - 0.06% (2)
for a cure - 0.06% (2)
and bogus treatments - 0.06% (2)
infectiousness and treatment - 0.06% (2)
how hiv works - 0.06% (2)
well with a - 0.06% (2)
"real time" boosts - 0.06% (2)
a major new - 0.06% (2)
individuals who want - 0.06% (2)
to take care - 0.06% (2)
of their health.visit - 0.06% (2)
our factsheets pagefind - 0.06% (2)
out more in - 0.06% (2)
our blog new - 0.06% (2)
service use up, - 0.06% (2)
it is planned - 0.06% (2)
a topic, providing - 0.06% (2)
drugs chart a - 0.06% (2)
the liver meeting - 0.06% (2)
catch up on - 0.06% (2)
syringe service use - 0.06% (2)
up, but a - 0.06% (2)
third of people - 0.06% (2)
still share needles - 0.06% (2)
11 hours ago - 0.06% (2)
easy-to-understand information for - 0.06% (2)
key aspects of - 0.06% (2)
low cd4 count - 0.06% (2)
website 23 october - 0.06% (2)
guide to the - 0.06% (2)
just found out - 0.06% (2)
reference guide to - 0.06% (2)
for hiv services - 0.06% (2)
here – our - 0.06% (2)
factsheets on hiv - 0.06% (2)
prevention and treatment - 0.06% (2)
of about hiv - 0.06% (2)
at the hiv - 0.06% (2)
overview of the - 0.06% (2)
hiv and aids. - 0.06% (2)
design of hiv - 0.06% (2)
factsheets nam has - 0.06% (2)
of the most - 0.06% (2)
important topics in - 0.06% (2)
hiv prevention, treatment - 0.06% (2)
and care.each factsheet - 0.06% (2)
gives a brief - 0.06% (2)
tailored to your - 0.06% (2)

Here you can find chart of all your popular one, two and three word phrases. Google and others search engines means your page is about words you use frequently.

Copyright © 2015-2016 hupso.pl. All rights reserved. FB | +G | Twitter

Hupso.pl jest serwisem internetowym, w którym jednym kliknieciem możesz szybko i łatwo sprawdź stronę www pod kątem SEO. Oferujemy darmowe pozycjonowanie stron internetowych oraz wycena domen i stron internetowych. Prowadzimy ranking polskich stron internetowych oraz ranking stron alexa.